Problems in continuity of medication management upon transition between primary and secondary care: patients' and professionals' experiences.


Journal

Acta clinica Belgica
ISSN: 2295-3337
Titre abrégé: Acta Clin Belg
Pays: England
ID NLM: 0370306

Informations de publication

Date de publication:
Aug 2019
Historique:
pubmed: 23 6 2018
medline: 27 12 2019
entrez: 23 6 2018
Statut: ppublish

Résumé

Patients often experience drug-related problems at admission or after discharge from hospital. The objective of this study was to identify the main problems in medication management at transition between settings of care, as experienced by health care professionals (HCPs) and patients. Focus group discussions were organised between December 2009 and February 2010; nine focus groups with primary and secondary care HCPs and patients and two with stakeholders. Focus group discussions were audiotaped and observation files were constructed. For the analysis, a thematic framework approach was used. Between November 2015 and April 2016, 19 additional interviews and 1 focus group were performed with general practitioners (GP) and community pharmacists (CP). This qualitative study provided a long list of problems that could be summarised in five clusters: (1) problems at admission, e.g. incomplete list of medication, absence of information in case of emergency admission; (2) problems at discharge, e.g. lack of communication with GP, insufficient supplies of medication for the weekend; (3) problems as to professions, e.g. GP's opinion different to that of the medical specialist; (4) problems as to patients and family, e.g. failure to understand treatment; (5) problems as to processes, e.g. medication substitutions. HCPs and patients experience many problems in medication management at transition between settings of care. The fact that these problems occur at different stages and persist over time stresses the necessity for multilevel solutions.

Sections du résumé

BACKGROUND AND OBJECTIVES OBJECTIVE
Patients often experience drug-related problems at admission or after discharge from hospital. The objective of this study was to identify the main problems in medication management at transition between settings of care, as experienced by health care professionals (HCPs) and patients.
METHODS METHODS
Focus group discussions were organised between December 2009 and February 2010; nine focus groups with primary and secondary care HCPs and patients and two with stakeholders. Focus group discussions were audiotaped and observation files were constructed. For the analysis, a thematic framework approach was used. Between November 2015 and April 2016, 19 additional interviews and 1 focus group were performed with general practitioners (GP) and community pharmacists (CP).
RESULTS RESULTS
This qualitative study provided a long list of problems that could be summarised in five clusters: (1) problems at admission, e.g. incomplete list of medication, absence of information in case of emergency admission; (2) problems at discharge, e.g. lack of communication with GP, insufficient supplies of medication for the weekend; (3) problems as to professions, e.g. GP's opinion different to that of the medical specialist; (4) problems as to patients and family, e.g. failure to understand treatment; (5) problems as to processes, e.g. medication substitutions.
CONCLUSION CONCLUSIONS
HCPs and patients experience many problems in medication management at transition between settings of care. The fact that these problems occur at different stages and persist over time stresses the necessity for multilevel solutions.

Identifiants

pubmed: 29932849
doi: 10.1080/17843286.2018.1483561
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

263-271

Auteurs

Veerle Foulon (V)

a Department of Pharmaceutical and Pharmacological Sciences, Clinical Pharmacology and Pharmacotherapy , KU Leuven , Leuven , Belgium.

Joke Wuyts (J)

a Department of Pharmaceutical and Pharmacological Sciences, Clinical Pharmacology and Pharmacotherapy , KU Leuven , Leuven , Belgium.

Franciska Desplenter (F)

a Department of Pharmaceutical and Pharmacological Sciences, Clinical Pharmacology and Pharmacotherapy , KU Leuven , Leuven , Belgium.
b Universitair Psychiatrisch Centrum KU Leuven - Z.org KU Leuven , Kortenberg , Belgium.

Anne Spinewine (A)

c Faculté de pharmacie et des sciences biomédicales , Louvain Drug Research Institute, Université catholique de Louvain , Brussels , Belgium.

Valérie Lacour (V)

c Faculté de pharmacie et des sciences biomédicales , Louvain Drug Research Institute, Université catholique de Louvain , Brussels , Belgium.

Dominique Paulus (D)

d Belgian Health Care Knowledge Centre , Brussels , Belgium.

Jan De Lepeleire (J)

e Department of Public Health and Primary Care , Academic Center for General Practice, KU Leuven , Leuven , Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH